Home » Optimer Pharma’s Antibiotic Succeeds in Late-Stage Trial Again
Optimer Pharma’s Antibiotic Succeeds in Late-Stage Trial Again
Optimer Pharmaceuticals Inc. announced positive results from the second of two late-stage trials of its investigational antibiotic, Fidaxomicin in patients with CDI (Clostridium difficile infection).
RTTNews
RTTNews
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May